Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001104659-26-042070
Filing Date
2026-04-10
Accepted
2026-04-10 16:31:03
Documents
21
Period of Report
2026-06-04

Document Format Files

Seq Description Document Type Size
1 DEF 14A capr-20260604xdef14a.htm   iXBRL DEF 14A 913963
2 GRAPHIC capr-20260604xdef14a_a002.jpg GRAPHIC 8333
3 GRAPHIC capr-20260604xdef14a_a003.jpg GRAPHIC 5528
4 GRAPHIC capr-20260604xdef14a_a010.jpg GRAPHIC 53689
5 GRAPHIC capr-20260604xdef14a_a011.jpg GRAPHIC 52905
6 GRAPHIC capr-20260604xdef14a_bg001.jpg GRAPHIC 123393
7 GRAPHIC capr-20260604xdef14a_bg002.jpg GRAPHIC 102902
  Complete submission text file 0001104659-26-042070.txt   2745914

Data Files

Seq Description Document Type Size
8 EX-101.SCH capr-20260604.xsd EX-101.SCH 3394
9 EX-101.DEF capr-20260604_def.xml EX-101.DEF 1968
10 EX-101.LAB capr-20260604_lab.xml EX-101.LAB 3685
11 EX-101.PRE capr-20260604_pre.xml EX-101.PRE 3925
24 EXTRACTED XBRL INSTANCE DOCUMENT capr-20260604xdef14a_htm.xml XML 347921
Mailing Address 10865 ROAD TO THE CURE SUITE 150 SAN DIEGO CA 92121
Business Address 10865 ROAD TO THE CURE SUITE 150 SAN DIEGO CA 92121 (310) 358-3200
CAPRICOR THERAPEUTICS, INC. (Filer) CIK: 0001133869 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-34058 | Film No.: 26855317
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)